Apica Acquires Data Fabric Trailblazer LOGIQ.AI and Raises $10M in New Funding to Modernize Data Management

STOCKHOLM, SWEDEN, Aug 17, 2023 – (ACN Newswire) – Apica, the leader in synthetic monitoring and observability, today announced its agreement to acquire observability data fabric startup LOGIQ.AI. Apica also announced it has raised $10 million in funding from existing investors Industrifonden, SEB Foundation, and Oxx. With the acquisition and the new financing, Apica plans to continue delivering affordable and flexible observability innovations and develop new capabilities in the coming months for enterprise customers.

Apica Acquires LOGIQ.ai

Today, IT teams must balance the need for standardization and cost reduction with the difficult task of consolidating monitoring tools, services, and network cost centers. With the acquisition of LOGIQ.AI and the funding announced today, Apica will deliver active observability, automated root cause analysis, and advanced data management to bridge real-world gaps in analysis.

"We are determined to address the need for low-cost infinite storage and observability to support businesses with relevant, actionable data," said Mathias Thomsen, CEO, Apica. "With the acquisition of LOGIQ.AI and the additional funding, we will deliver 'Active Observability' that combines observability and synthetic monitoring into a proactive platform to plug data gaps and put business data in context."

"What makes Apica's new offering unique is the merger of an observability data fabric with synthetic monitoring. In a world where 'downtime is death,' solving monitoring and observability in a streamlined and cost-efficient way is crucial for businesses," said Mikael Johnsson, General Partner and co-founder, Oxx. "This novel approach of 'active observability' has also been extremely challenging for enterprises with complex data structures or in highly regulated sectors to deploy successfully. With this move, Apica is able to provide companies with an end-to-end observability solution, enabling a broader range of companies to incorporate observability successfully into their operations. Apica is setting a new standard for 'active observability' and at Oxx, we are excited to see where the Apica team takes this next."

"Joining Apica with LOGIQ's data fabric platform creates an innovative and intelligent approach to data management," said Ranjan Parthasarathy, CEO of LOGIQ. "Together, we are empowering businesses to thrive where data-driven insights meet flawless performance, shaping the future of our customers' digital success."

Active Observability With Synthetics and User Control

The Apica Ascent platform with LOGIQ.AI gives users complete data pipeline control, a unified view of all information, and infinite high-quality storage at the lowest cost on the market. The platform acts as a superior indexing tool that aggregates data such as logs, traces, network packets, etc., from multiple sources and improves data quality by trimming off excess data and performing enrichments. The data can be shifted from the platform to a lake environment – either Apica's or another data lake. The result is a unified view of all data for faster root cause analysis while slashing costs and eliminating vendor lock.

"We are offering active observability on your terms," said Jason Haworth, CPO, Apica. "We can give you observability at a low cost that scales to exabytes and gives you your data in context when and how you need it. We're also stacking all this functionality into our data lakes and indexers while embracing open standards such as OpenTelemetry. This allows us to be application, device, service, and vendor agnostic. Having these pieces in place lets us be that decoder ring that other vendors in the space just can't do."

The LOGIQ.AI capabilities will be added to the Apica Ascent platform and deployed to current customers in Q3 of this year.

Connect With Apica
Twitter https://pr.report/4NDq76H3
LinkedIn https://pr.report/JfnauHm3

About Apica

Apica keeps enterprises operating. The Ascent platform delivers active observability, automated root cause analysis, and advanced data management to quickly find and resolve complex digital performance issues before they negatively impact the bottom line. Today, business operations depend on understanding the health of multi-cloud, hybrid, and on-premises environments to keep business-critical applications and systems online while providing an optimal user experience. Apica delivers a unified view of all information for the entire technology stack, helping reduce, prevent, and resolve outages and lost revenue. For more information, visit www.apica.io.

Media Contact:
Ben Jolley
Benjamin.Jolley@apica.io
(801) 592-0806

Contact Information:
Ben Jolley
VP of Marketing
benjamin.jolley@apica.io
801.592.0806

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Beverly Hills Based IMA ART Fertility Launches We Create Heirs Marketing Campaign Serving China’s Uber-Wealthy

BEVERLY HILLS, CA, Aug 17, 2023 – (ACN Newswire) – Patek Philippe Geneve is synonymous with the next generation. IMA ART Fertility helps its Chinese Clientele create the next generation through access to the world's finest network of specialists in the fields of fertility and reproductive law.

IMA ART Fertility Co-Founders
IMA ART Fertility provides a trusted avenue towards family creation.

Launching the first of its kind We Create Heirs(R) fertility & surrogacy campaign exclusively serving China's super wealthy, IMA ART embarks upon a truly unique adventure to capture the senses, imagination and desires of discreet high-net-worth families. IMA ART Fertility's singular focus is helping discerning Chinese clientele build their families – and the next generation – by utilizing the full suite of advanced assisted reproductive technologies, including gender selection, PGT (pre-implantation genetic testing), ICSI (Intracytoplasmic sperm injection) & surrogacy. California's progressive legal framework allows for any single person, LGBTQ and heterosexual couple to become parents – these are luxuries not legally available outside the U.S.

"Indeed, there can be no grander luxury than our children. IMA ART redefined a new paradigm in fertility," said Michelle Tang, CEO, Co-Founder & Ethnic Chinese.

Unfortunately, for many, this ultimate luxury requires a little help – that's where IMA ART Fertility's bespoke family journey comes in. The Co-Founders' imaginations know no limit when it comes to going above and beyond, with infinite creative freedom to design Chinese guests' ultra-personalized experience for the next generation. At IMA ART, nobody does what they do at the high level they do it.

Wealthy Chinese clients inherently understand having more children diversifies their generational risk. Wealthy Chinese families are pragmatic and understand competition between their offspring ensures the family's assets are ultimately passed down to that child with the most ability – offspring who will carry on the family lineage to future generations.

Having one child carries enormous risks for affluent Chinese families. If that offspring is incapable, it is believed the family will collapse. More children minimizes the risk, maximizes social development and the future success of the family over future generations. Chinese families have experienced many upheavals and challenges during their long history. IMA ART Fertility provides a trusted avenue towards successfully continuing the family bloodline.

Traveling across Hong Kong, Shenzhen, Beijing and Shanghai, Co-Founders Michelle Tang and Ron Sonnenberg have taken their case to the super private lives of China's mega-wealthy. Families who have achieved unimaginable success and who demand the very best in all their endeavors. This is especially important in the field of international fertility & surrogacy arrangements.

About the Company: Privately held IMA ART offers the first-of-its-kind significant, unique, and consistently elevated luxury fertility experiences to intended parents from around the world. The firm's bespoke professional advisory services provide transformative luxury concierge services paired with fertility & surrogacy in Beverly Hills. The company's exclusive suite of discreet fertility options is exclusively available to busy high-net-worth individuals. Learn more.

Contact Information:
Ron Sonnenberg
Co-Founder
ron@imaartfertility.com
(424)-284-1408

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

BayWa r.e. sells Karadoc Solar Farm and enters into Strategic Development Agreement with Atmos Renewables

SYDNEY, AU, Aug 17, 2023 – (ACN Newswire) – Global renewable energy developer, service provider, and solar distributor BayWa r.e. announces the sale of the Karadoc solar farm and the strategic development partnership with Atmos Renewables (Atmos) for a series of wind projects, marking a significant milestone in the company's commitment to renewable energy development in Australia. BayWa r.e. is committed to the redeployment of resources from the sales proceed and further investments in its existing pipeline of 5GW in the Australian renewables market.

The Karadoc solar farm represents BayWa r.e.'s first owned and built solar plant in Australia, and it stands as one of Australia National Electricity Market (NEM)'s largest operating solar projects in terms of capacity. Situated around 25 km south of Mildura, Victoria, Karadoc has a capacity of 112.5 MWp and became operational in 2019. Featuring over 346,000 solar panels, this facility generates sufficient energy to cater to 47,000 households.

The partnership between BayWa r.e. and Atmos, a prominent player in the Australian renewable energy landscape, underscores BayWa r.e.'s dedication to fostering sustainable growth in Australia. It leverages Atmos' local expertise and BayWa r.e.'s global experience, creating a formidable force for developing a series of wind projects across the country.

Daniel Gaefke, Director of Projects APAC, BayWa r.e. AG., said, "At BayWa r.e., we are committed to advancing the global transition towards clean energy. The sale of Karadoc combined with the strategic development partnership with Atmos as well as our growing renewable pipeline are a testament to this commitment. Our strategic partnership for a series of wind development projects with Atmos exemplifies our efforts to synergize local insight and international expertise for the betterment of Australia's renewable energy landscape."

BayWa r.e. sees Australia as an important market and is committed to growing the renewable energy sector in the region. The renewable energy developer continues to contribute to Australia's future of clean energy with a strong pipeline of projects.

The transaction stands as a remarkable achievement in BayWa r.e.'s portfolio, which has completed more than 300 MW of installed capacity in the country and symbolizes the company's progress in the renewable energy domain.

BayWa r.e. AG (BayWa r.e.)

At BayWa r.e. we r.e.think energy – how it is produced, stored and can be best used to enable the global renewable energy transition that is essential to the future of our planet.

We are a leading global developer, service supplier, distributor and solutions provider and have brought over 5.5 GW of energy online and manage over 10 GW of assets. We are also an Independent Power Producer with an expanding energy trading business.

BayWa r.e. works with businesses worldwide to provide tailored renewable solutions. Operating 100% carbon neutral, we are also committed to our own sustainability journey.

Every day, we are working hard to actively shape the future of energy in a diverse, equitable and inclusive workplace.

Our shareholders are BayWa AG, a EUR27.1 billion global business, and Energy Infrastructure Partners, a leader in energy infrastructure investment.

Contact information:

Mark Cooper
Head of Global Communications
Tel: +49 89 383932 3611
E-mail: mark.cooper@baywa-re.com

Salim Pathan
Marketing Manager, APAC
Tel: +66 62 698 7162
E-mail: salim.pathan@baywa-re.com

PRecious Communications for BayWa r.e. APAC
Tel: +65 6303 0567
E-Mail: baywa-re@preciouscomms.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Ensign InfoSecurity Recognized As Outstanding Cybersecurity Solutions Provider At PIKOM Unicorn Tech Awards 2023

KUALA LUMPUR, Aug 17, 2023 – (ACN Newswire) – Ensign InfoSecurity ("Ensign"), Asia's largest pure-play end-to-end cybersecurity solutions provider, has won Special Recognition as the Best Managed Security Service Provider at the PIKOM Unicorn Tech Awards 2023.

Hosted by PIKOM, the National Tech Association of Malaysia, the awards recognize excellent contributions, achievements, and dedication in tech fields.

"We are delighted to have won the Special Recognition as the Best Managed Security Service Provider at the PIKOM Unicorn Tech Awards 2023", shared Tammie Tham, Group Chief Executive Officer, Ensign InfoSecurity. "We are grateful that the team's hard work and dedication have been recognized, and this motivates us to keep working towards our commitment to empowering our clients with cutting-edge solutions to fortify their cyber defences."

Ensign's Managed Security Services seamlessly integrate proprietary AI-Powered Cyber Analytics, a potent tool in countering cyber threats. Its strengths lie in training on extensive anonymized datasets, leveraging expert insights, and adopting the MITRE ATT&CK framework to identify behaviours of advanced attackers. Delivered via Ensign's Security Operation Centers (EnSOCs), it provides real-time monitoring for on-premises and hybrid cloud environments. Ensign's aim is to assist organizations in strengthening their security posture and optimizing cyber investments while safeguarding their valuable digital assets.

Ensign places a strong emphasis on proactive and early threat detection to effectively neutralize potential risks. In pursuit of early threat identification, Ensign has recently released the 4th edition of its Cyber Threat Landscape 2023 report, providing a deep analysis of the cyber threat groups and vulnerable sectors in the APAC territories of Singapore, Malaysia, Indonesia, South Korea, and Hong Kong. This reflects Ensign's commitment to providing cutting-edge insights for a robust security posture.

About Ensign InfoSecurity

Ensign InfoSecurity is the largest, pure-play end-to-end cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients' cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.

Ensign InfoSecurity is ranked 6th in a worldwide survey of MSSPs (Managed Security Services Providers).
For more information, visit www.ensigninfosecurity.com or email marketing@ensigninfosecurity.com

For Media Enquiries
PRecious Communications for Ensign,
ensign@preciouscomms.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

New CGFNS Survey of Immigrant Nurses in the U.S. Reveals Their Economic Impact

PHILADELPHIA, PA, Aug 16, 2023 – (ACN Newswire) – In addition to helping alleviate a chronic nursing shortage in the United States, immigrant nurses are estimated to spend well over $46 billion annually in the U.S. economy while providing hundreds of millions more in financial support to family members back home, according to a report from CGFNS International, a global leader in credentials evaluation services that support health worker mobility.

The Economics of Nurse Migration report is based on a survey of more than 1,500 foreign-educated nurses who have used the organization's credentials verification services to facilitate their migration to the U.S. The results offer a window into the economic experiences and impact of nurse immigrants working in the U.S., as well as the driving reasons for their migration.

The report can be downloaded from cgfns.org/eonm23.

"This report quantifies the financial costs and sacrifices associated with nurse migration while highlighting the substantial contributions that immigrant nurses make to host countries and the economies of both the host and sending nations," said Dr. Peter Preziosi, CGFNS International's President and CEO.

In the survey, the main reasons nurses cited for migrating were largely balanced across three key drivers – familial (31 percent), professional (29 percent) and economic (25 percent). In terms of their economic impact, the survey results showed:

The average salary for respondents was $65,700 within the first three years of arrival and $71,800 overall, compared with $89,000 average salary for registered nurses in the U.S. A quarter of respondents reported making more than $90,000 annually.

Immigrant nurses reported spending 60 percent of their income in their communities on housing, other necessities and local shopping, with another 25 percent for taxes.

Two-thirds (66 percent) send money home to friends and family on a regular basis – averaging about five percent of their spending. Of those that sent money, 44 percent reported sending home more than 10 percent of their monthly salary.

Extrapolating from other data showing there are 688,000 immigrants in the U.S. nursing workforce of more than 4.3 million, the CGFNS report estimates that after sending $1.6 billion in remittances to the communities they left, immigrant nurses spend at least $46.9 billion annually in the U.S. economy.

About half (52 percent) of nurse immigrants reported engaging a recruiter to handle their migration process. However, that proportion rises to 79 percent when narrowing the sample to those who migrated in the past three years.

Fifty-two percent of survey respondents who used a recruitment firm elected to use a Certified Ethical Recruiter (CER), a designation given to those firms that agree to additional oversight by CGFNS's Alliance for Ethical Recruitment Practices and comply with its ethical code.

"By illuminating these essential aspects of nurse migration to the United States, we aim to provide policymakers, healthcare leaders, and stakeholders with a comprehensive perspective that transcends mere statistics and embraces the inherent value of immigrant nurses to both America's health systems and economy," said Preziosi.

About CGFNS International, Inc.

Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. CGFNS International is an NGO in Consultative Status with the United Nations Economic and Social Council (ECOSOC) and is a member of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO). For more information, visit https://www.cgfns.org.

Contact Information:
Mukul Bakhshi, Esq.
Chief of Strategy and Government Affairs
mbakhshi@cgfns.org
(215) 243-5825

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22%

HONG KONG, Aug 16, 2023 – (ACN Newswire) – Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review").

Financial Performance Returned to Pre-COVID-19 Operating Level

During the period under review, the Group achieved a consolidated revenue of approximately HK$899 million, with an increase of 37.1% as compared to the same period last year, indicating normalcy in business to the pre-COVID-19 operating level. The profit of the Group increased by 22.0% to approximately HK$170 million as compared to approximately HK$139.2 million for the same period last year.

As of 30 June 2023, the Group had cash and cash equivalents of approximately HK$506 million (31 December 2022: approximately HK$543 million). The Board is pleased to propose an interim dividend of HK$0.045 (For the six months ended 30 June 2022: HK$0.04) per ordinary share for the six months ended 30 June 2023.

Revenue Growth in Ophthalmology and Surgical Segments

The Group's revenue is primarily made up of the segments of Ophthalmology and Surgical (wound care and healing). For the six months ended 30 June 2023, the revenue of Ophthalmology increased by 41.6% to approximately HK$382 million, accounting for approximately 42.4% of the Group's revenue, while the revenue of Surgical up 34.0% to approximately HK$518 million, representing approximately 57.6% of the Group's revenue. The core products that are as current growth driver under each segment are:

1. Ophthalmology – Beifushu series (Beifushu eye drops, Beifushu eye gel and Beifushu unit-dose eye drops), Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops and Iodized Lecithin Capsules; and

2. Surgical (Wound care and healing) – Beifuji series (Beifuji spray, Beifuji lyophilised powder and Beifuxin gel), Carisolv dental caries removal gel, Dr. YaDian mouth wash,Yi Xue An Granules and PELNAC collagen-based artificial dermis.

Significant Business Development Activities

The Group is committed to pragmatically investing in new products and technologies to strengthen the Group's product and research and development ("R&D") pipeline as near to mid-term growth driver in ophthalmology and long-term plan for new therapeutics in oncology. During the period under review, major investments in ophthalmic products that are currently in an advanced stage of clinical development are outlined as follows:

Re-establishing the VISTA programme after the acquisition of SkQ1's intellectual property rights

In order to provide the Group with flexibility and independence in the continuing development of the US FDA VISTA programme in the field of dry eye disease and to allow the Group to explore further the development of products for other ophthalmic indications, the Group successfully secured a patent assignment deed and a patent and know-how licence agreement relating to SkQ1 in the field of ophthalmology from Mitotech.

Following the acquisition of the intellectual property rights relating to SkQ1 on 13 October 2022, the Group's priority is to complete the transfer of chemistry, manufacturing and controls (CMC), know-how and intellectual property rights relating to SkQ1 from Mitotech. Concurrently, the Group is re-establishing the VISTA programme with regulators for mitigating any identifiable risks before continuing with the clinical trial. According to Frost & Sullivan, the estimated number of patients with moderate-to-severe dry eye disease was around 119.7 million in the PRC in 2020. It is expected that the size of the potential market of the SkQ1 product will be significant.

EB12-20145P (HLX04-O) global phase 3 clinical study makes significant progress

In 2020, the Group entered into a co-development and exclusive licence agreement with Shanghai Henlius Biotech, Inc. to co-develop a pharmaceutical product (EB12-20145P), a recombinant anti-vascular endothelial growth factor ("anti-VEGF") humanised monoclonal antibody injection for the treatment of exudative (wet) age-related macular degeneration ("wet-AMD"). As at the date of this announcement, the product has been approved to commence phase 3 clinical trials in Australia, the United States, Singapore, Russia, Serbia and European Union countries such as Hungary, Spain, Latvia, the Czech Republic and Poland. So far, the first patient has been dosed in a phase 3 clinical study for EB12-20145P for the treatment of wet-AMD in the PRC, Latvia, Australia and the United States. Also, the phase 1/2 clinical study for EB12-20145P for the treatment of wet-AMD has shown its safety and tolerability and demonstrated preliminary efficacy.

In February 2023, the Group entered into an amendment agreement with Henlius to amend certain terms of the co-development and exclusive license agreement, which included payments for regulatory and commercial sales milestones and development costs in respect of the Anti-VEGF licensed product, details of which are in the announcement dated 22 February 2023 and the annual results announcement on 8 March 2023.

The Anti-VEGF Licensed Product can be used for treating wet-AMD, diabetic macular edema, macular edema caused by retinal vein occlusion and myopic choroidal neovascularisation. According to Frost & Sullivan, the estimated number of patients with these 4 categories of disease was around 15.8 million in the PRC in 2020. Assuming each patient applies 4 doses in the first year of treatment and 2 to 3 doses in subsequent years, it is expected that the size of the potential market of the Anti-VEGF licensed product will be significant.

Honors and Awards Obtained In 2023

Zhuhai Essex Bio-Pharmaceutical Company Limited, a wholly-owned subsidiary of the Group, has been recognised as one of the 2022 top 100 innovative companies in Zhuhai, and has also been recognised as one of the 2022 top 100 chemical pharmaceutical companies in the PRC. The Group's Beifushu has been awarded as one of the Chinese reputable medicine brands in five consecutive years. This is a testament to the recognition by the industry for the efficacy and quality of our flagship biologic drug.

Market Development Entrenched Market Access Capability

The Group has been relentlessly investing in establishing and strengthening its market access capability. As at 30 June 2023, the Group maintains a network of 43 regional sales offices in the PRC with a total number of more than 1,200 sales and marketing representatives, covering more than 12,100 hospitals and medical providers, coupled with more than 2,100 pharmaceutical stores, which are widely located in the major cities, provinces and county cities in the PRC. Sales to lower-tier cities is supplemented by on-line platform for medical consultation and e-prescription, the on-line platform is further deployed for serving patients with chronic diseases.

The Group's expansion of its market access into Southeast Asian countries via its base in Singapore has been gaining good development traction since 2020.

Research and Development

During the period under review, the Group remains focused executing its 5-year (2021 to 2025) R&D's development plans. As at 30 June 2023, there are 16 R&D programmes in the pre-clinical to clinical stage, out of which the following 4 ophthalmology programmes are as mid-term growth drivers:

— EB11-18136P: SkQ1 eye drops, second phase 3 clinical trial (US FDA) (VISTA-2) topline data released on 24 February 2021
— EB11-15120P: Azithromycin eye drops, ongoing review by external key opinion leaders (National Medical Products Administration ("NMPA") in the PRC)
— EB12-20145P: Bevacizumab for wet age-related macular degeneration ("wet-AMD"), phase 3 clinical trial (US FDA, European Medicines Agency, Therapeutic Goods Administration and NMPA in the PRC)
— EB11-21148P: Cyclosporine eye drops, phase 2 clinical trial (NMPA in the PRC)

The Group holds a total of 73 patent certificates or authorisation letters, which include 52 invention patents, 14 utility model patents and 7 design patents. The Group currently has diversified its R&D resources to multiple research sites in Zhuhai (PRC), Boston (United States), London (United Kingdom) and Singapore which support not only our pursuit of new therapeutics but also our recruitment of global talents.

Mr. Patrick Ngiam, Chairman of Essex, said, "With tenacity and strength, we are pleased to return our business performance to the pre-COVID-19 operating level. Barring any unforeseen circumstances, being resilient, relevant and growth ready, the Group is optimistic of delivering progressive results.

I would like to take this opportunity to express my sincere gratitude to all stakeholders, business associates and valued customers for the trust, support and cooperation accorded to us, and each and every member of the Group for their relentless efforts rendered in shaping the Group into being a progressive and promising pharmaceutical player."

About Essex (1061.HK)
Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic b-bFGF (FGF-2), having six commercialised biologics marketed in China since 1998. Additionally, it has a portfolio of commercialised products of preservative-free unit-dose eye drops and Iodized Lecithin Capsules etc.. The products of the Company are principally prescribed for the treatment of wounds healing and diseases in Ophthalmology and Dermatology, which are marketed and sold through approximately 12,100 hospitals and managed directly by its 43 regional sales offices in China. Leveraging on its in-house R&D platform in growth factor and antibody, the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields and indications.

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Mitrade Redefines Its Brand Identity, Debuts New Logo and AI Features

MELBOURNE, AUSTRALIA, Aug 16, 2023 – (ACN Newswire) – Mitrade unveils its revamped branding logo along with a new slogan, “Trade Faster, Trade Smarter”, to perfectly embody their vision of crafting the ultimate trading experience for traders. The new branding direction is implemented with a range of innovative enhancements aimed at providing traders with the best tools and resources.

Mitrade changed its logo and slogan to better define its brand identity. With a strategic shift towards “Trade Faster, Trade Smarter”, the new logo shows a modern and AI-inspired design, connecting with traders who are into technology and innovation. The incorporation of updated bright colors not only adds vibrancy but also signifies the dynamic and innovative nature of the trading platform.

Trade Faster, Trade Smarter Anytime, Anywhere

Mitrade enables users to dive into a trading experience that empowers them to act with speed, backed by the insights they need to trade smart – no matter where they are. Building on this brand innovation, Mitrade has masterfully woven in the capabilities of TradingView, ensuring a smooth and integrated user experience. Furthermore, with the introduction of MitradeGPT, users are now equipped with tools to make faster decisions while trading on Mitrade.

Prioritizing speed, Mitrade has flawlessly incorporated TradingView, a platform trusted by over 550 million unique users, into its trading interface. This integration brings TradingView’s sleek and comprehensive interface to Mitrade’s platform, empowering traders to effortlessly conduct technical analysis, make well-informed predictions, and execute trades seamlessly.

To assist traders in keeping in touch with the market pulse, Mitrade has integrated ChatGPT and FXStreet news insights into its platform, making the company first in the CFD world to have this kind of feature. With MitradeGPT, users can access real-time insights, personalized guidance and a quick summary to navigate the complexities of financial markets – filtering out the noise from the bustling news environment. MitradeGPT is available in the brand’s mobile application.

Mitrade Academy Now Available In 10 Languages

Along with the change of the brand’s new slogan, Mitrade reveals the expansion of Mitrade Academy’s educational resources in 10 languages. This launch shows Mitrade’s dedication to helping traders worldwide by giving them easy-to-understand learning materials in their native languages. By offering an extensive range of educational content, including tutorials and trading guides, in languages such as English, Spanish, Thai, Vietnamese, and more, Mitrade aims to break down language barriers and foster a more inclusive and informed trading community.

Social Links

Facebook: https://www.facebook.com/MitradeOfficial

Twitter: https://twitter.com/MitradeOfficial

LinkedIn: https://www.linkedin.com/company/mitradecom/

Instagram: https://www.instagram.com/mitrade_official/

YouTube: https://www.youtube.com/c/Mitradeglobal/

Media Contact:

Mitrade Media team

E-mail: branding@mitrade.com

Website: https://www.mitrade.com/

SOURCE: Mitrade

Revolutionising Regenerative Medicine in Asia: A Landmark Collaboration between HealthPro Pharma, Fior Bioscience, and Medi Lifestyle

KUALA LUMPUR, Aug 16, 2023 – (ACN Newswire) – Medi Lifestyle Limited, a renowned Singapore-listed frontrunner in healthcare innovation, today unveiled a momentous collaboration between its indirect wholly-owned subsidiaries, HealthPro Pharma Pte Ltd (HPP) and Healthpro Marketing Sdn. Bhd (HPM), with FIOR Bioscience, LLC and Shine Bioscience, LLC (SBS).

Dato' Ken Low, Executive Director and Chief Executive Officer of Medi Lifestyle

This groundbreaking partnership promises to not only accelerate access to cutting-edge stem cell therapy products but to catalyse a revolution in healthcare, positioning regenerative medicine at the forefront of modern treatment across Asia.

The collaboration will meld the unique and complementary strengths of HPP, HPM, SBS, and Fior Bioscience, united by a shared vision of enhancing patient outcomes and breaking new ground in medical innovation. Fior Bioscience, with over a decade and a half of dedicated experience, stands as a perfect alignment to Medi Lifestyle's steadfast commitment to elevating healthcare standards through quality, innovation, and ethical practices.

Shine Bioscience, as the handpicked exclusive distributor for this collaboration's revolutionary stem cell therapy products, will capitalise on its far-reaching connections to Asia's elite laboratories, fuelling both research and development and streamlining distribution across the vibrant region.

Dato' Ken Low, Executive Director and Chief Executive Officer of Medi Lifestyle emphasised, "We aim to import and distribute FDA-registered stem cell therapy products and lead localised research and development efforts. By driving innovation and maintaining the highest safety and ethical standards, we dedicate ourselves to our patients' well-being and satisfaction."

Mr. David Kasteler, Managing Director of Shine Bioscience, added, "This collaboration signifies a milestone in making stem cell therapies accessible and effective in Asia. Together with Fior Bioscience's pioneering research and the patient-centric approach of Healthpro Pharma and Healthpro Marketing, we're committed to transforming healthcare across the region."

Medi Lifestyle's strategic move solidifies its stance as a leader in preventive healthcare. The partnership encapsulates an ethos of pioneering technology, uncompromising safety measures, and world-class expertise that converge to set new benchmarks in stem cell treatment options.

With registered offices and clinics extending their reach to Petaling Jaya, Malaysia, Medi Lifestyle continues to break barriers and redefine healthcare for the future.

Medi Lifestyle Ltd: https://www.medi-lifestyle.com/

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Digital Transformation Summit Indonesia

JAKARTA, Aug 16, 2023 – (ACN Newswire) – Indonesia's path toward a prosperous future hinges on its ability to leverage the digital economy.

In Indonesia, digital transformation has transcended its role as a mere economic enabler; it has now become a cornerstone of the nation's economic advancement. The advancement of a country's digital sector is intricately interwoven with its economic foundation and can be envisioned as an unceasing cycle of growth that mutually reinforces and accumulates over time.

Consequently, Indonesia stands at a critical juncture where calibrated digital integration promises unprecedented growth, but a mismanaged approach could deepen inequalities and stall progress. Thus, a comprehensive and considerate strategy is vital to fully harness the digital realm's potential for the nation's enduring welfare and growth.

Amid Jakarta's vibrant landscape, the 24th Digital Transformation Summit gathers distinguished businesses, institutions, and government bodies. An exclusive invitation-only event, it offers pivotal IT decision-makers a unique opportunity for face-to-face interactions. Anchored in the theme "Unlocking DX Strategies to Meet the Digital Age," the summit fosters collaboration, addresses challenges, and shapes Indonesia's path. With a dynamic 2-stage program, it draws 750+ C-Level Executives and thought leaders.

The conference features two vibrant stages: InfoTech and MarTech, offering immersive journeys into technology and marketing realms. InfoTech guides through the evolving IT landscape, with thought leaders exploring trends in software, AI, cybersecurity, and cloud computing. MarTech illuminates the fusion of marketing and technology, revealing strategies that amplify customer engagement via digital tools, analytics, social media, and automation. Attendees gain rich insights, connections, and inspiration across these stages, transcending field boundaries. This dynamic experience fuels innovation and networking, fostering a deeper understanding of the ever-evolving tech and marketing landscapes.

What is InfoTech?

The conference covers diverse themes, from enhancing citizen-state interactions through digital tech to stressing pragmatic strategies for effective digital transformations. It highlights balanced approaches in strategy and execution. Discussions spotlight how edge computing can enhance 5G potential in Indonesia. Emphasizing security integration into organizational DNA mitigates risks in an interconnected landscape. Overall, the conference underscores digitalization as pivotal for a sustainable future, driving efficiency, inclusivity, and innovation.

In-depth discussions on topics like:

DAY-1
– Using Digital Technologies to Upgrade Citizen – State Interaction.
– How is Pragmatic Approach the key to a successful digital transformation?
– Beyond Human Imagination: The Power of Generative AI

DAY-2
– Embedding Security into Organizaon's DNA.
– Is digitalization the key to a sustainable future?

What is MarTech?
The MarTech stage delves into diverse marketing technology aspects, offering insights into optimising tech stacks for maximum impact. The emerging metaverse's transformative potential for marketing's future is showcased. Discussions spotlight customers' pivotal role in digital transformation strategies. Omnichannel experiences are explored for seamless platform interactions. Generative AI's power in upscaling businesses is highlighted, fostering innovation. Collectively, these topics shape a dynamic narrative, underscoring marketing technology's evolving landscape and profound influence on strategies and customer engagement.
Insightful talks on:

DAY-1
– Who is truly in the driving seat of your Digital Transformation Strategy?
– How will Metaverse shape the future of Marketing?
– Are You Getting the Most from Your Marketing Tech Stack?

DAY-2
– Why Focus on Omnichannel Customer Experience?
– Role of Generative AI in up-scalingFireSide Chat Businesses.

Who will attend?

The Digital Transformation Summit, Indonesia will be attended by top executives and leaders like CIO, CTO, CDO, CISO, CMO, Heads of Customer Experience, Head of Customer Relation Management, Heads Of IT ,Product & Brand Heads and Head UI/UX & Design from a variety of industries including BFSI & Fintech, Manufacturing, Cloud Ecommerce & Retails, Government, Energy & Utilities, Healthcare, Telecom, Pharma & Life sciences and Education
For more information on Digital Transformation Summit, Indonesia, you can visit
https://digitransformationsummit.com/indonesia/

About Exito:

Exito, which means success in Spanish, embodies our commitment to the success of our customers. Each year, we host over 240 virtual and in-person conferences globally, bringing together audiences with world-class thought leaders and C-level executives across industries. Our meticulously crafted agendas, based on extensive research and valuable industry insights, facilitate business, knowledge transfer, deal flow, and impactful messaging for brands.

Contact: Mithun Gopinath,
Manager-Projects,
Exito Media Concepts
mithun.gopinath@exito-e.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Society Pass Inc (Nasdaq: SOPA) / Thoughtful Media Enter Philippines Market and Launch Creator Economy Focused Advertising Platform

SoPa officially launches Thoughtful Media Group (TMG), the leading digital advertising platform in Southeast Asia, in the Philippines market.
TMG will present its Philippines executive team and disruptive influencer advertising business model at a media presentation in Manila on Thursday, 17 August 2023.
TMG has expanded its ecosystem of multi-platform advertising services through a network of more than 10,000 talented creators across multiple industries in Thailand, Vietnam, Indonesia and Philippines, assisting brands maximise marketing budgets and achieve significant revenue generation.

Manila, Aug 16, 2023 – (ACN Newswire) – Society Pass Incorporated (Nasdaq: SOPA) (“SoPa”), Southeast Asia (SEA)’s next generation, data-driven, loyalty, fintech and e-commerce ecosystem, today announces the official launch of its digital advertising platform, Thoughtful Media Group Inc (TMG), in the Philippines market. With the theme of “The Power of Influence”, TMG will introduce its new Manila-based executive team and its disruptive influencer advertising business model at a media presentation at 4 pm on Thursday, 17 August 2023 at Mansion Sports Bar & Lounge, OPL Building, 100 Don Carlos Palanca, Legazpi Village, Makati, 1229 Metro Manila, Philippines.

Established in 2010 and acquired by SoPa in 2022, TMG’s growth trajectory has been impressive. In just 12 months, TMG has grown from operating exclusively in its headquarters of Bangkok, Thailand, to expanding to Vietnam in 4Q 2022, to Indonesia in 1Q 2023 and now to Philippines in 3Q 2023. In addition, TMG’s employee count has increased from just 15 professionals in July 2022 to over 75 staff today. With an influencer network of more than 10,000 talented creators, an integrated roster of digital advertising products and services including influencer marketing and brand campaigns, social commerce, and sports marketing, and 13 years of experience serving more than 100 brands, TMG’s market entry into the Philippines market offers a significant value proposition to advertisers, merchants, and influencers in SEA’s fourth largest economy. Well positioned to benefit from Philippine’ forecast soaring digital advertising revenues over the next decade as increasingly more consumers make direct purchases on social media platforms, TMG collaborates with social media platforms, advertisers and influencers to develop the entire creator economy in Philippines.

Mr. Dennis Nguyen, SoPa Founder/Chairman/CEO and TMG Chairman, states, “We are very pleased to bring the Philippines market into the TMG ecosystem. TMG’s disruptive advertising platform, combining over 10,000 talented creators, market-leading design/branding capabilities, influencer advertising-focused social commerce services, will generate massive storytelling capabilities and revenue generation opportunities for local, regional and international advertisers seeking to market in Philippines. By leveraging our local knowledge of market trends from other offices in Thailand, Vietnam, and Indonesia, TMG provides international quality advertising products and services for our brand partners as well as a significant revenue generating opportunities for Philippines creators”.

Mr Nguyen continues, “I am very excited to hire Billy Soo to head our TMG Philippines operations. Billy brings a wealth of experience in gaming and advertising from his time at Gushcloud International, Nixgen Entertainment and Powerplay Inc. I look forward to seeing Billy and his team create the most unique and powerful advertising platform here in Philippines”.

Although currently at a nascent stage, the Philippines creator economy is experiencing a dynamic surge, driven by a tech-savvy population and widespread internet access. According to Datareportal, Philippines’s internet penetration rate stood at 73.1 percent of the total population at the start of 2023 with the number of internet users increasing by 10 million between 2022 and 2023. Furthermore, Filipinos spend a combined 3 hours and 43 minutes a day on social media. INSG forecasts the value of SEA’s influencer marketing industry to reach US$2.59 billion in 2024, up from US$638 million in 2019 alone.

Responsible for driving sales and onboarding Philippines clients onto TMG’s regional digital advertising platform, Mr. Billy Soo, Country Head of Thoughtful Media Group Philippines, comments, “Bonding through the power of influence, we want to create a genuine connection for brands and content creators, tapping onto TMG’s broad advertising network and extensive ecosystem to open new doors towards more business opportunities, capitalising on digital-first and fully integrated advertising networks. Mr. Nguyen hired me to turbocharge TMG’s expansion here in the land of the Kabayan. In just five weeks’ time, we have already built a staff of 10+ Manila-based advertising professionals. TMG Philippines will offer premium branded campaigns, MCN, sports marketing and e-sports verticals and we look forward to serving the creator and advertiser communities”.

About Thoughtful Media Group Inc.

Founded in 2010, Thoughtful Media Group is the leading digital advertising platform in SEA. Through our network of more than 10,000 talented creators across multiple industries in Thailand, Vietnam, Indonesia and Philippines, we help brands maximise marketing budgets and achieve business objectives through some of the most innovative marketing campaigns in the region.

In July 2022, Society Pass (Nasdaq: SOPA), the next generation acquisition-focused fintech and e-commerce ecosystem in SEA, acquired Thoughtful Media Group Inc. Since then, TMG has fully evolved into a digital-first and fully integrated advertising powerhouse, servicing creators and advertisers in SEA.

For more information on TMG, please visit:

Website at www.thoughtfulmedia.com or

LinkedIn at https://www.linkedin.com/company/thoughtful-media-group-inc or

Instagram at https://www.instagram.com/thoughtfulmedia/ or

Facebook at https://www.facebook.com/thoughtfulmediaasia or

Twitter at https://twitter.com/ThoughtfulMedia.

About Society Pass Inc.

Founded in 2018 as a data-driven loyalty, fintech and e-commerce ecosystem in the fast-growing markets of Vietnam, Indonesia, Philippines, Singapore and Thailand, which account for more than 80% of the SEA population, and with offices located in Angeles, Bangkok, Ho Chi Minh City, Jakarta, Manila, and Singapore, Society Pass Incorporated (Nasdaq: SOPA) is an acquisition-focused holding company operating 6 interconnected verticals (loyalty, digital media, travel, telecoms, lifestyle, and F&B), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA.

Society Pass completed an initial public offering and began trading on the Nasdaq under the ticker SOPA in November 2021.

SoPa acquires fast growing e-commerce companies and expands its user base across a robust product and service ecosystem. SoPa integrates these complementary businesses through its signature Society Pass fintech platform and circulation of its universal loyalty points or Society Points, which has entered beta testing and is expected to launch broadly at the beginning of 2023. Society Pass loyalty program members earn and redeem Society Points and receive personalised promotions based on SoPa’s data capabilities and understanding of consumer shopping behaviour. SoPa has amassed more than 3.3 million registered consumers and over 650,000 registered merchants and brands. It has invested 2+ years building proprietary IT architecture to effectively scale and support its consumers, merchants, and acquisitions.

Society Pass leverages technology to tailor a more personalised experience for customers in the purchase journey and to transform the entire retail value chain in SEA. SoPa operates Thoughtful Media Group, a Thailand-based, a social commerce-focused, premium digital video multi-platform network; NusaTrip, a leading Indonesia-based Online Travel Agency; VLeisure, Vietnam’s leading provider of hotel management and payment solutions; Gorilla Global, a Singapore-based, mobile network operator; Leflair.com, Vietnam’s leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in Philippines; and NextGen Retail, a Indonesia-based e-commerce platform.